PLAUR and familial pancreatic carcinoma: To evaluate whether α6β1-integrin and uPAR affect activation of Ras and ERK, pancreatic cancer cells were treated for 30 min with the inhibitory antibodies before being exposed to rIL-1α for 30 min.